nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—Terbutaline—BCHE—multiple sclerosis	0.101	0.563	CrCbGaD
Bupranolol—Clenbuterol—TNF—multiple sclerosis	0.0786	0.437	CrCbGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00351	0.00428	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00345	0.00421	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00344	0.00419	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—LINGO1—multiple sclerosis	0.00343	0.00419	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.00342	0.00417	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CXCL10—multiple sclerosis	0.00339	0.00413	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00338	0.00412	CbGpPWpGaD
Bupranolol—ADRB1—G alpha (s) signalling events—POMC—multiple sclerosis	0.00336	0.00409	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.00335	0.00408	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00331	0.00403	CbGpPWpGaD
Bupranolol—ADRB2—G alpha (s) signalling events—POMC—multiple sclerosis	0.00328	0.004	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.00327	0.00398	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CXCL13—multiple sclerosis	0.00325	0.00396	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCR1—multiple sclerosis	0.00325	0.00396	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.0032	0.0039	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00318	0.00387	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00311	0.00379	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TAGAP—multiple sclerosis	0.00298	0.00363	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00293	0.00358	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CCL5—multiple sclerosis	0.00292	0.00356	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00288	0.00351	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00287	0.0035	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00282	0.00343	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.0027	0.00329	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CCL3—multiple sclerosis	0.00268	0.00326	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00264	0.00322	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00264	0.00322	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CCR5—multiple sclerosis	0.00263	0.0032	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CCL3—multiple sclerosis	0.00262	0.00319	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—S1PR1—multiple sclerosis	0.00261	0.00319	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—S1PR1—multiple sclerosis	0.0026	0.00317	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00258	0.00315	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—PTGER4—multiple sclerosis	0.00258	0.00314	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—S1PR1—multiple sclerosis	0.00256	0.00312	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—GPC5—multiple sclerosis	0.00253	0.00309	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—PTGER4—multiple sclerosis	0.00252	0.00307	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CXCR3—multiple sclerosis	0.00249	0.00303	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00245	0.00299	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—RGS1—multiple sclerosis	0.00245	0.00298	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CXCR3—multiple sclerosis	0.00243	0.00297	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CCR2—multiple sclerosis	0.00242	0.00295	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—RGS1—multiple sclerosis	0.00239	0.00292	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00239	0.00291	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00237	0.00289	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CCR2—multiple sclerosis	0.00237	0.00289	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00234	0.00285	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—GPR65—multiple sclerosis	0.00232	0.00283	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCL3—multiple sclerosis	0.00231	0.00282	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CCR2—multiple sclerosis	0.0023	0.00281	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00227	0.00277	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—GPR65—multiple sclerosis	0.00227	0.00277	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CNR1—multiple sclerosis	0.00223	0.00272	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PTGER4—multiple sclerosis	0.00223	0.00272	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00222	0.00271	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—RGS1—multiple sclerosis	0.00222	0.00271	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RGS1—multiple sclerosis	0.00221	0.0027	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CNR1—multiple sclerosis	0.00218	0.00266	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—RGS1—multiple sclerosis	0.00217	0.00265	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CXCR3—multiple sclerosis	0.00215	0.00262	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CNR1—multiple sclerosis	0.00213	0.00259	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CCR1—multiple sclerosis	0.00212	0.00259	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00212	0.00259	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—GPR65—multiple sclerosis	0.00211	0.00257	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—GPR65—multiple sclerosis	0.0021	0.00256	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCR2—multiple sclerosis	0.00209	0.00255	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00208	0.00253	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CCR1—multiple sclerosis	0.00208	0.00253	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—GPR65—multiple sclerosis	0.00206	0.00251	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—POMC—multiple sclerosis	0.00205	0.0025	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00205	0.0025	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—LINGO1—multiple sclerosis	0.00204	0.00248	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CXCL10—multiple sclerosis	0.00201	0.00245	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CCL2—multiple sclerosis	0.00201	0.00245	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.002	0.00244	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—LINGO1—multiple sclerosis	0.00199	0.00243	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CXCL10—multiple sclerosis	0.00197	0.0024	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CNR1—multiple sclerosis	0.00193	0.00235	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCR1—multiple sclerosis	0.00193	0.00235	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CXCL13—multiple sclerosis	0.00193	0.00235	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCR1—multiple sclerosis	0.00192	0.00234	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CXCL13—multiple sclerosis	0.00192	0.00234	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00191	0.00233	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CXCL13—multiple sclerosis	0.00188	0.0023	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCR1—multiple sclerosis	0.00188	0.0023	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TAGAP—multiple sclerosis	0.00177	0.00215	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CXCL10—multiple sclerosis	0.00174	0.00212	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CCL5—multiple sclerosis	0.00173	0.00211	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TAGAP—multiple sclerosis	0.00173	0.00211	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CCL5—multiple sclerosis	0.00169	0.00206	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CCL5—multiple sclerosis	0.00165	0.00201	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.0016	0.00195	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00157	0.00191	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00157	0.00191	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CCR5—multiple sclerosis	0.00156	0.0019	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—S1PR1—multiple sclerosis	0.00154	0.00188	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00153	0.00187	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CCR5—multiple sclerosis	0.00153	0.00186	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—S1PR1—multiple sclerosis	0.00151	0.00184	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GPC5—multiple sclerosis	0.0015	0.00183	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCL5—multiple sclerosis	0.0015	0.00182	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CCR5—multiple sclerosis	0.00148	0.00181	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GPC5—multiple sclerosis	0.00147	0.00179	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—IL2RA—multiple sclerosis	0.00146	0.00178	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00146	0.00177	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00142	0.00174	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00141	0.00171	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00137	0.00168	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCL3—multiple sclerosis	0.00137	0.00167	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CCR2—multiple sclerosis	0.00137	0.00167	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCL3—multiple sclerosis	0.00137	0.00167	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCR5—multiple sclerosis	0.00135	0.00164	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCL3—multiple sclerosis	0.00134	0.00164	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CCR2—multiple sclerosis	0.00134	0.00163	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL2RA—multiple sclerosis	0.00133	0.00162	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PTGER4—multiple sclerosis	0.00132	0.00161	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PTGER4—multiple sclerosis	0.00132	0.0016	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RGS1—multiple sclerosis	0.00131	0.0016	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PGR—multiple sclerosis	0.0013	0.00158	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PTGER4—multiple sclerosis	0.00129	0.00158	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RGS1—multiple sclerosis	0.00128	0.00157	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CXCR3—multiple sclerosis	0.00128	0.00156	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CXCR3—multiple sclerosis	0.00127	0.00155	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CNR1—multiple sclerosis	0.00126	0.00154	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CD28—multiple sclerosis	0.00126	0.00153	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CXCR3—multiple sclerosis	0.00125	0.00152	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GPR65—multiple sclerosis	0.00124	0.00152	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCR2—multiple sclerosis	0.00124	0.00151	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCR2—multiple sclerosis	0.00124	0.00151	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CNR1—multiple sclerosis	0.00123	0.00151	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—POMC—multiple sclerosis	0.00122	0.00149	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GPR65—multiple sclerosis	0.00122	0.00148	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCR2—multiple sclerosis	0.00121	0.00148	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CCL2—multiple sclerosis	0.00119	0.00145	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—POMC—multiple sclerosis	0.00119	0.00145	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CCL2—multiple sclerosis	0.00117	0.00142	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—POMC—multiple sclerosis	0.00116	0.00141	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CNR1—multiple sclerosis	0.00115	0.0014	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CNR1—multiple sclerosis	0.00114	0.00139	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCR1—multiple sclerosis	0.00114	0.00139	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCL13—multiple sclerosis	0.00114	0.00139	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00114	0.00139	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CNR1—multiple sclerosis	0.00112	0.00137	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCR1—multiple sclerosis	0.00111	0.00136	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCL13—multiple sclerosis	0.00111	0.00136	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00111	0.00136	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—POMC—multiple sclerosis	0.00105	0.00128	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CXCL10—multiple sclerosis	0.00103	0.00126	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CCL2—multiple sclerosis	0.00103	0.00126	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CXCL10—multiple sclerosis	0.00103	0.00125	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CXCL10—multiple sclerosis	0.00101	0.00123	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000978	0.00119	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CCL5—multiple sclerosis	0.000957	0.00117	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—TYK2—multiple sclerosis	0.000936	0.00114	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CD86—multiple sclerosis	0.000898	0.00109	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCL5—multiple sclerosis	0.000888	0.00108	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCL5—multiple sclerosis	0.000884	0.00108	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000881	0.00107	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCL5—multiple sclerosis	0.000869	0.00106	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000868	0.00106	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CCR5—multiple sclerosis	0.000862	0.00105	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—IL2—multiple sclerosis	0.000858	0.00105	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000849	0.00104	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SPP1—multiple sclerosis	0.000819	0.000998	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL3—multiple sclerosis	0.000811	0.000989	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCR5—multiple sclerosis	0.0008	0.000976	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCR5—multiple sclerosis	0.000796	0.000971	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL3—multiple sclerosis	0.000793	0.000967	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000789	0.000962	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL2RA—multiple sclerosis	0.000785	0.000957	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCR5—multiple sclerosis	0.000783	0.000954	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PTGER4—multiple sclerosis	0.000781	0.000952	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL2—multiple sclerosis	0.000779	0.00095	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL2RA—multiple sclerosis	0.000771	0.000941	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PGR—multiple sclerosis	0.000769	0.000938	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PTGER4—multiple sclerosis	0.000764	0.000931	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCR3—multiple sclerosis	0.000754	0.000919	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PGR—multiple sclerosis	0.000752	0.000917	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CD28—multiple sclerosis	0.000747	0.000911	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCR3—multiple sclerosis	0.000738	0.000899	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCR2—multiple sclerosis	0.000733	0.000894	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CD28—multiple sclerosis	0.000731	0.000891	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—APOE—multiple sclerosis	0.000724	0.000883	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCR2—multiple sclerosis	0.000718	0.000875	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—POMC—multiple sclerosis	0.000689	0.00084	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CNR1—multiple sclerosis	0.000677	0.000825	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—POMC—multiple sclerosis	0.000674	0.000821	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CNR1—multiple sclerosis	0.000662	0.000807	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CD80—multiple sclerosis	0.000655	0.000799	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—POMC—multiple sclerosis	0.000625	0.000762	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—POMC—multiple sclerosis	0.000622	0.000759	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCL2—multiple sclerosis	0.000612	0.000746	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—POMC—multiple sclerosis	0.000612	0.000746	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCL10—multiple sclerosis	0.000609	0.000743	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCL2—multiple sclerosis	0.000609	0.000743	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCL2—multiple sclerosis	0.000599	0.00073	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCL10—multiple sclerosis	0.000596	0.000727	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—MAPK1—multiple sclerosis	0.000596	0.000726	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—TYK2—multiple sclerosis	0.000556	0.000677	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TYK2—multiple sclerosis	0.000553	0.000674	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—TYK2—multiple sclerosis	0.000543	0.000663	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CD86—multiple sclerosis	0.000533	0.00065	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL5—multiple sclerosis	0.000525	0.00064	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CD86—multiple sclerosis	0.000521	0.000636	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL5—multiple sclerosis	0.000513	0.000626	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—IL2—multiple sclerosis	0.000509	0.000621	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—IL2—multiple sclerosis	0.000498	0.000607	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SPP1—multiple sclerosis	0.000486	0.000592	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SPP1—multiple sclerosis	0.000475	0.00058	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCR5—multiple sclerosis	0.000473	0.000576	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL2RA—multiple sclerosis	0.000466	0.000568	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCR5—multiple sclerosis	0.000462	0.000564	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL2—multiple sclerosis	0.000462	0.000564	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL2—multiple sclerosis	0.00046	0.000561	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL6—multiple sclerosis	0.000458	0.000558	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL2RA—multiple sclerosis	0.000456	0.000556	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL2—multiple sclerosis	0.000452	0.000551	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MMP9—multiple sclerosis	0.000435	0.000531	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—APOE—multiple sclerosis	0.00043	0.000524	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—APOE—multiple sclerosis	0.000421	0.000513	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CD80—multiple sclerosis	0.000389	0.000474	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—STAT3—multiple sclerosis	0.000387	0.000472	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CD80—multiple sclerosis	0.00038	0.000464	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—POMC—multiple sclerosis	0.000369	0.00045	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL2—multiple sclerosis	0.000361	0.000441	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—POMC—multiple sclerosis	0.000361	0.000441	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MYC—multiple sclerosis	0.00036	0.000439	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TGFB1—multiple sclerosis	0.000359	0.000438	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000354	0.000431	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL2—multiple sclerosis	0.000354	0.000431	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MAPK1—multiple sclerosis	0.000352	0.000429	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—MAPK1—multiple sclerosis	0.000346	0.000422	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TYK2—multiple sclerosis	0.000328	0.0004	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TYK2—multiple sclerosis	0.000321	0.000391	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL2—multiple sclerosis	0.000273	0.000333	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL6—multiple sclerosis	0.000272	0.000331	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL6—multiple sclerosis	0.00027	0.00033	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL2—multiple sclerosis	0.000267	0.000326	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL6—multiple sclerosis	0.000266	0.000324	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MMP9—multiple sclerosis	0.000258	0.000315	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MMP9—multiple sclerosis	0.000253	0.000308	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—STAT3—multiple sclerosis	0.00023	0.00028	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—STAT3—multiple sclerosis	0.000225	0.000274	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MYC—multiple sclerosis	0.000214	0.00026	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TGFB1—multiple sclerosis	0.000213	0.00026	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MAPK1—multiple sclerosis	0.000209	0.000255	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MYC—multiple sclerosis	0.000209	0.000255	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TGFB1—multiple sclerosis	0.000208	0.000254	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MAPK1—multiple sclerosis	0.000204	0.000249	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL6—multiple sclerosis	0.000161	0.000196	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL6—multiple sclerosis	0.000157	0.000191	CbGpPWpGaD
